Davenport & CO LLC Omeros Corp Transaction History

Davenport & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 28, 2020	SELL	$12.21 - $16.99 $823,564 - $1.15 Million	-67,450 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$9.03 - $19.72 $27,089 - $59,160	-3,000 Reduced 4.26%	67,450 $902,000
Q4 2019 Jan 22, 2020	SELL	$13.01 - $17.15 $10,408 - $13,719	-800 Reduced 1.12%	70,450 $993,000
Q2 2019 Jul 10, 2019	BUY	$15.0 - $19.62 $120,000 - $156,960	8,000 Added 12.65%	71,250 $1.12 Million
Q1 2019 Apr 17, 2019	BUY	$11.65 - $17.72 $102,520 - $155,936	8,800 Added 16.16%	63,250 $1.1 Million
Q2 2018 Jul 09, 2018	SELL	$10.79 - $24.44 $371,715 - $841,958	-34,450 Reduced 38.75%	54,450 $988,000
Q1 2018 Apr 04, 2018	BUY	$9.0 - $20.16 $85,500 - $191,520	9,500 Added 11.96%	88,900 $993 Million
Q3 2017 Oct 12, 2017	BUY	$19.76 - $24.9 $1.57 Million - $1.98 Million	79,400	79,400 $1.72 Billion

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $762M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Davenport & CO LLC with notifications on news.